The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers.
 
Michael Offin
Consulting or Advisory Role - PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Chongrui Xu
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
 
Harsh Jain
No Relationships to Disclose
 
Alex Makhnin
No Relationships to Disclose
 
Sara A. Hayes
No Relationships to Disclose
 
Andrew J. Plodkowski
No Relationships to Disclose
 
Darragh Halpenny
No Relationships to Disclose
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo; Elucida Oncology; Genentech/Roche; Harpoon Therapeutics; Ipsen; Loxo; PharmaMar; PharmaMar; Seagen
Research Funding - Abbvie/Stemcentrx (Inst); Daiichi Sankyo (Inst); Merck (Inst); Viralytics (Inst)
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Memorial Sloan-Kettering Cancer Center
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Taiho Pharmaceutical; Teva
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Guardant Health; Hengrui Therapeutics; Mersana; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Daiichi Sankyo (Inst); GRAIL (Inst); Guardant Health (Inst); Hengrui Therapeutics (Inst); Illumina (Inst); Roche/Genentech (Inst)
 
Paul K. Paik
Honoraria - Abbvie; Celgene; Lilly; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Lilly
Research Funding - Celgene; EMD Serono
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Takeda